MarketPulse

ophthalmic disease management

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Harrow Raises $50M via Senior Notes as Ophthalmic Firm Funds Growth

Harrow prices $50M in senior unsecured notes due 2030, expanding existing debt facility for product development and strategic initiatives.
HROWproduct developmentcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Harrow to Release 2025 Financial Results on March 2

Harrow Health will release 2025 financial results March 2, 2026, reaffirming $270-$280 million revenue guidance and highlighting its expanding pharmaceutical portfolio.
HROWfinancial resultsrevenue guidance